Pinealon: what it is and what the evidence says
A short peptide (bioregulator family) studied for its relationship with neuronal function and cognitive protection. It is the tripeptide EDR, proposed to enter the neuron's nucleus and modulate the expression of antioxidant defense genes.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
The brain adapts by forming and strengthening connections. Neurotransmitters take part in that conversation, along with factors that help neurons survive and grow. Compounds in this group are studied for their relationship with focus, memory, mood or neuroprotection — and it is worth saying plainly that this is the area where claims are most exaggerated and where human evidence is thinnest.
What it is studied for
Focus, cognitive protection.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
In people there are Russian open-label studies by the oral route, with no placebo group. One from 2015 was done in older adults with several chronic conditions and organic brain syndrome, and another, summarized in the 2020 review, in 72 patients after a traumatic brain injury; they describe better memory and fewer headaches.
The limitation that matters most
Randomized placebo-controlled trials, replications by independent groups, and human pharmacokinetic data are still missing. Nearly all the literature comes from the same Russian institute, and some of the papers study combinations of short peptides.
Regulatory status
Not approved by the FDA or the EMA; in Russia it is distributed as an oral capsule within the bioregulator line. It was not among the peptides the FDA reviewed for compounding in 2026. It does not appear by name on the 2026 WADA Prohibited List; as an unapproved substance it may fall under category S0, so anyone who competes under anti-doping testing should confirm its status with their federation.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Human safety data are limited, and its possible effect on serotonin calls for attention if you are on antidepressants. Watch for mood changes, insomnia, or a headache that persists.
With a neurological condition, memory lapses that are getting worse, pregnancy, or antidepressant treatment, have a professional assess it before you start.
What this page cannot give you
A reference page can take you this far. You know what Pinealon is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a Certificate of Completion with a verifiable certificate ID, a Progress Tracker to follow how you are doing, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processespreclinical Rejuvenation Res · 2011 · PMID 21978084 →
- Pinealon protects the rat offspring from prenatal hyperhomocysteinemiapreclinical Int J Clin Exp Med · 2012 · PMID 22567179 →
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNApreclinical Biochemistry (Mosc) · 2011 · PMID 22117547 →
- Short peptides stimulate serotonin expression in cells of brain cortexpreclinical Bull Exp Biol Med · 2014 · PMID 24909721 →
- [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]human Adv Gerontol · 2015 · PMID 26390612 →
- EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Diseasereview Molecules · 2020 · PMID 33396470 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Pinealon or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Pinealon?
A short peptide (bioregulator family) studied for its relationship with neuronal function and cognitive protection. It is the tripeptide EDR, proposed to enter the neuron's nucleus and modulate the expression of antioxidant defense genes. It is studied within the area of cognitive.
Is there human evidence for Pinealon?
In people there are Russian open-label studies by the oral route, with no placebo group. One from 2015 was done in older adults with several chronic conditions and organic brain syndrome, and another, summarized in the 2020 review, in 72 patients after a traumatic brain injury; they describe better memory and fewer headaches.
Is it approved by any health agency?
Not approved by the FDA or the EMA; in Russia it is distributed as an oral capsule within the bioregulator line. It was not among the peptides the FDA reviewed for compounding in 2026. It does not appear by name on the 2026 WADA Prohibited List; as an unapproved substance it may fall under category S0, so anyone who competes under anti-doping testing should confirm its status with their federation.
What is the dose of Pinealon?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Pinealon is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.